HOME › DRUGS › REMIBRUTINIB
ACTIVE SUBSTANCE / INN

REMIBRUTINIB

Brand name(s): RHAPSIDO, Rhapsido
FDA LISTED
EMA LISTED
PRESCRIPTION
OPINION
NDA218436
Urticaria
ACTIVE SUBSTANCE
Remibrutinib
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS, Novartis Europharm Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RHAPSIDONDA218436NOVARTISPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RhapsidoNovartis Europharm LimitedOpinionUrticaria

FULL INTELLIGENCE ON REMIBRUTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →